Description

Fraxiparin Solution for Injections Syringe 0.4m (3800 IU/0.4 ml.) №10

Ingredients:

Fraxiparin contains enoxaparin sodium, which is a low molecular weight heparin.

Dosage:

The recommended dosage of Fraxiparin is determined by the healthcare provider based on the patient’s condition and weight. It is administered subcutaneously.

Indications:

Fraxiparin is indicated for the prevention of blood clots in conditions such as deep vein thrombosis and pulmonary embolism. It is also used in the treatment of certain heart conditions.

Contraindications:

Do not use Fraxiparin if you have a history of heparin-induced thrombocytopenia or are at risk of excessive bleeding. Consult your doctor for more information.

Directions:

Administer the injection as directed by your healthcare provider. Do not self-inject unless instructed. Rotate injection sites and do not rub the area after injection.

Scientific Evidence:

Studies have shown that enoxaparin, the active ingredient in Fraxiparin, effectively prevents blood clots with a lower risk of side effects compared to unfractionated heparin.

Additional Information:

It is important to monitor for signs of bleeding or bruising while using Fraxiparin. Inform your healthcare provider of any unusual symptoms. Store the syringes at room temperature.

Pharmacological Effects: Fraxiparin works by inhibiting the formation of blood clots. It enhances the activity of antithrombin III, which in turn inhibits factors Xa and IIa in the coagulation cascade, preventing clot formation.

Clinical Trials: Clinical trials have demonstrated the efficacy of Fraxiparin in preventing venous thromboembolism in various patient populations, including those undergoing surgery and patients with acute medical conditions. The drug has shown comparable effectiveness to other low molecular weight heparins with a favorable safety profile.